 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | FL-301 / Leap Therap
Enrollment change, Trial completion date, Trial withdrawal, Trial primary completion date, Metastases: Phase 1/2a Study to Evaluate FL-301 in Patients With Advanced Solid Tumors (clinicaltrials.gov) - Feb 6, 2022
P1/2, N=0, Withdrawn, Sponsor: Flame Biosciences
N=115 --> 0 | Trial completion date: Feb 2024 --> Jan 2022 | Not yet recruiting --> Withdrawn | Trial primary completion date: Feb 2024 --> Jan 2022
- |||| FL-301 / Leap Therap
New P1/2 trial, Metastases: Phase 1/2a Study to Evaluate FL-301 in Patients With Advanced Solid Tumors (clinicaltrials.gov) - Jan 6, 2022
P1/2, N=115, Not yet recruiting, Sponsor: Flame Biosciences
- | FL-301 / Leap Therap
New P1 trial, Metastases: NBL-015-CSP-001: Evaluation of the Safety and Efficacy of NBL-015 in Patients With Advanced Solid Tumors (clinicaltrials.gov) - Dec 10, 2021
P1, N=410, Not yet recruiting, Sponsor: NovaRock Biotherapeutics, Ltd